Investing Profile

Jason Rhodes

Partner at Atlas Venture

Your Intro Paths to Jason Rhodes

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Jason is a member of

Yale University Network

289 CONNECTIONS

Atlas Venture Network

25 CONNECTIONS

Find Jason Rhodes on

Current Investing Position

Investment Range

$500K - $5.0M

Sweet Spot

$2.0M

Investments On Record

Jason Rhodes is on these Sector & Stage Rankings

Jason Rhodes's Investments On Record (11)

Company	StageDateRound Size	Total Raised
AAVantgarde Bio	Series BNov 2025$140M Series AJun 2023$65M	$210M
Co-investors: Paola Pozzi (Sofinnova Partners), Graziano Seghezzi (Sofinnova Partners), Dmitrij Hristodorov (Forbion), David Steinberg (Longwood Fund)
Be Biopharma	Series CJan 2025$92M Series UnknownOct 2024$82M Series BApr 2022$130M Series AOct 2020$52M	$360M
Co-investors: Steven Gillis (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners), Melissa McCracken (Nextech Invest)
Accent Therapeutics	Series CJan 2024$75M Series BApr 2020$63M Series AMay 2018$40M	$180M
Co-investors: Larry Lasky (The Column Group), Naveen Krishnan (Leaps by Bayer)
K36 Therapeutics	Series BJun 2023$70M Series ADec 2021$30M	$100M
Co-investors: Chong Xu (F-Prime Capital Partners), Melissa McCracken (Nextech Invest)
Rectify Pharmaceuticals	Series AOct 2021$100M	$100M
Co-investors: Marco Boorsma (Forbion), David Steinberg (Longwood Fund), Jodie Morrison (Atlas Venture), Rajesh Devraj (Atlas Venture)
Gemini Therapeutics	Post Ipo EquityFeb 2021$95M Series AOct 2017$43M SeedApr 2016$2M	$140M
Co-investors: Stephen Squinto (OrbiMed), Carl Gordon (OrbiMed Advisors), Jean George (Advanced Technology Ventures)
Generation Bio	Series CJan 2020$110M Series AJan 2018$25M	$140M
Third Harmonic Bio	Series AJan 2019$50M	$50M
Co-investors: David Bonita (OrbiMed), Michael Gladstone (Atlas Venture)